141 related articles for article (PubMed ID: 37276644)
1. Prevalence and correlates of cannabis use among individuals with DSM-5 social anxiety disorder: Findings from a nationally representative sample.
Patel TA; Schubert FT; Zech JM; Cougle JR
J Psychiatr Res; 2023 Jul; 163():406-412. PubMed ID: 37276644
[TBL] [Abstract][Full Text] [Related]
2. Correlates of alcohol use and alcohol use disorder among individuals with DSM-5 social anxiety disorder: A population based study.
Patel TA; Cole SL; Cougle JR
J Affect Disord; 2024 Sep; 360():55-61. PubMed ID: 38821365
[TBL] [Abstract][Full Text] [Related]
3. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).
Buckner JD; Heimberg RG; Schneier FR; Liu SM; Wang S; Blanco C
Drug Alcohol Depend; 2012 Jul; 124(1-2):128-34. PubMed ID: 22266089
[TBL] [Abstract][Full Text] [Related]
4. Cannabis use and social anxiety disorder in emerging adulthood: Results from a nationally representative sample.
Single A; Alcolado G; Keough MT; Mota N
J Anxiety Disord; 2024 Jan; 101():102808. PubMed ID: 38061325
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity and Quality of Life in DSM-5 Social Anxiety Disorder Among a Nationally Representative Sample.
Patel TA; Schubert FT; Cougle JR
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38814117
[No Abstract] [Full Text] [Related]
6. Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study.
Brown QL; Shmulewitz D; Sarvet AL; Young-Wolff KC; Howard T; Hasin DS
Drug Alcohol Depend; 2023 Jul; 248():109940. PubMed ID: 37267745
[TBL] [Abstract][Full Text] [Related]
7. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use.
Shmulewitz D; Budney AJ; Borodovsky JT; Bujno JM; Walsh CA; Struble CA; Livne O; Habib MI; Aharonovich E; Hasin DS
J Psychiatr Res; 2023 Jul; 163():211-221. PubMed ID: 37224773
[TBL] [Abstract][Full Text] [Related]
8. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States.
Kerridge BT; Mauro PM; Chou SP; Saha TD; Pickering RP; Fan AZ; Grant BF; Hasin DS
Drug Alcohol Depend; 2017 Dec; 181():223-228. PubMed ID: 29107786
[TBL] [Abstract][Full Text] [Related]
9. [Comorbidity in 207 cannabis users in a specific outpatient setting].
Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions.
Khan SS; Secades-Villa R; Okuda M; Wang S; Pérez-Fuentes G; Kerridge BT; Blanco C
Drug Alcohol Depend; 2013 Jun; 130(1-3):101-8. PubMed ID: 23182839
[TBL] [Abstract][Full Text] [Related]
11. Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities.
Boyd CJ; Veliz PT; McCabe SE
Subst Abus; 2020; 41(2):191-195. PubMed ID: 31638867
[No Abstract] [Full Text] [Related]
12. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
[TBL] [Abstract][Full Text] [Related]
13. Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys.
Onaemo VN; Fawehinmi TO; D'Arcy C
J Affect Disord; 2021 Feb; 281():467-475. PubMed ID: 33360749
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cannabis use disorder among individuals using medical cannabis at admission to inpatient treatment for substance use disorders.
N S Gendy M; Taisir R; Sousa S; Costello J; Rush B; Busse JW; Mackillop J
Addict Behav; 2023 Jul; 142():107667. PubMed ID: 36893511
[TBL] [Abstract][Full Text] [Related]
15. Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample.
Kevorkian S; Bonn-Miller MO; Belendiuk K; Carney DM; Roberson-Nay R; Berenz EC
Psychol Addict Behav; 2015 Sep; 29(3):633-8. PubMed ID: 26415060
[TBL] [Abstract][Full Text] [Related]
16. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study.
Feingold D; Livne O; Rehm J; Lev-Ran S
Drug Alcohol Rev; 2020 Feb; 39(2):142-151. PubMed ID: 31916333
[TBL] [Abstract][Full Text] [Related]
17. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
[TBL] [Abstract][Full Text] [Related]
18. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.
Fink DS; Shmulewitz D; Mannes ZL; Stohl M; Livne O; Wall M; Hasin DS
J Psychiatr Res; 2022 Nov; 155():387-394. PubMed ID: 36182768
[TBL] [Abstract][Full Text] [Related]
19. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
20. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
Hayley AC; Stough C; Downey LA
Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
